Skip to content

Journey II BCS CMS Total Knee System Compared to Other PS Total Knee Systems in PT Setting

A Non-Randomized, Prospective Study of Short Term Outcomes Following Total Knee Replacement With JOURNEY™ II BCS Total Knee System Compared to Other Posterior Stabilized Total Knee Systems in a Physical Therapy Setting

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02820766
Enrollment
22
Registered
2016-07-01
Start date
2016-09-30
Completion date
2017-04-27
Last updated
2017-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Arthritis, Osteoarthritis, Traumatic Arthritis

Keywords

Posterior Stabilized Knee, Total Knee Arthroscopy, Journey II BCS

Brief summary

The primary objective of the study is to determine how the short-term outcome of subjects implanted with the JOURNEY™ II BCS Total Knee System compares to subjects implanted with other PS total knee systems, and to determine if there is a difference in health care resources consumed that may result in economic savings to patients, the facility and/or the payer. To address the study objectives, patient self-assessment questionnaires, and other objective measures of post-operative function and health care resource utilization will be used for data collection.

Interventions

None listed

Sponsors

Smith & Nephew, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Undergone unilateral primary total knee replacement with a JOURNEY™ II BCS Total Knee System or other Non-Smith & Nephew Posterior Stabilized Knee System * Will be initiating outpatient PT ≤ 7 days post-operatively * Has a primary diagnosis of osteoarthritis, degenerative arthritis, or traumatic arthritis * Has pre-operative ROM ≥ 90° * Is skeletally mature in the PI judgment * Is 21 years of age of older * Is willing and able to participate in required follow-up visits at the study site and to complete study procedures and questionnaires * Has consented to participate in the study by signing the IRB/EC approved informed consent for the study * Agrees to follow post- operative physical therapy program

Exclusion criteria

* Significant preoperative varus or valgus deformities (\>15º) * Has received a constrained or deep dish tibial insert * Morbid obesity (BMI \> 40) * Has not obtained required pre-rehabilitation, pre-operative and intra-operative records by week 2 visit * Other comorbidities that may impact outcomes such as osteoporosis, uncontrolled diabetes and active infection * Fibromyalgia requiring treatment * Current or impending incarceration or is a prisoner * In the opinion of the PI has an emotional or neurological condition that would pre-empt their ability or willingness to participate in the study including mental illness, mental retardation, drug or alcohol abuse * Is known to be at risk for lost to follow-up, or failure to return for scheduled visits * Undergone or is planning to undergo total knee replacement of the contralateral knee within 6 months of this total knee replacement * Requires a Legally Authorized Representative to consent to the study

Design outcomes

Primary

MeasureTime frameDescription
Difference in Knee Range of Motion (ROM) at the first outpatient Physical Therapy (PT) visit (≤7 days of surgery) between the 2 treatment groups≤7 days of surgeryThe absolute Range of Motion of index knee will be compared between groups

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026